Genomic advancements
Merck (known as MSD outside the United States and Canada) and BGI (formerly known as Beijing Genomics Institute) have recently announced the signing of a statement of intent to initiate and develop a working relationship in which they will explore areas of mutual interest in healthcare research and discovery.
Merck (known as MSD outside the United States and Canada) and BGI (formerly known as Beijing Genomics Institute) have recently announced the signing of a statement of intent to initiate and develop a working relationship in which they will explore areas of mutual interest in healthcare research and discovery. Their common goal will be to create value from the massive output of genomic information enabled by next-generation, high-throughput DNA sequencing and analysis technologies.
Commenting on the statement of intent, Peter S. Kim, president of Merck Research Laboratories, said, “The science and technology of genomics and epigenetics offer the potential to transform medicine. We are excited to move forward towards a collaboration with BGI in our efforts to advance these areas of research.”
Both companies intend to build the infrastructure to support collaboration in areas such as biomarkers, target validation and drug de-risking and development among others.
For more information on BGI visit www.genomics.cn and www.bgiamericas.com and for MSD, please visit www.merck.com
Best of the Week: Food Analysis, Chemical Migration in Plastic Bottles, STEM Researcher of the Year
December 20th 2024Top articles published this week include the launch of our “From Lab to Table” content series, a Q&A interview about using liquid chromatography–high-resolution mass spectrometry (LC–HRMS) to assess chemical hazards in plastic bottles, and a piece recognizing Brett Paull for being named Tasmanian STEM Researcher of the Year.
Using LC-MS/MS to Measure Testosterone in Dried Blood Spots
December 19th 2024Testosterone measurements are typically performed using serum or plasma, but this presents several logistical challenges, especially for sample collection, storage, and transport. In a recently published article, Yehudah Gruenstein of the University of Miami explored key insights gained from dried blood spot assay validation for testosterone measurement.
Determination of Pharmaceuticals by Capillary HPLC-MS/MS (Dec 2024)
December 19th 2024This application note demonstrates the use of a compact portable capillary liquid chromatograph, the Axcend Focus LC, coupled to an Agilent Ultivo triple quadrupole mass spectrometer for quantitative analysis of pharmaceutical drugs in model aqueous samples.
